Ref.: BL-RE-091455Manufacturer ref.: EHGCGX5 5 x 96 tests
€2,950.00 excl. VAT
Kit ELISA Glucagon sandwich (Hu GCG) (human): quantitative determination of Hu GCG in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu GCG.
Accession number
P01275
Dose range
2.03 pg/ml to 130 pg/ml
Sensitivity of the dosage
2.5 pg/ml
Calibration range
2.5 pg/ml to 130 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA Glucagon sandwich (Hu GCG) (human): quantitative determination of Hu GCG in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu GCG.
Kit ELISA Glucagon sandwich (Hu GCG) (human): quantitative determination of Hu GCG in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu GCG.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Glucagon is a polypeptide hormone composed of 29 amino acids (molecular weight 3482), produced in the pancreas. A related hormone, the enteroglucagon (or oxyntomodulin), which is produced in the mucosa of the small and large intestines, consists of the sequence of 29 amino acids of pancreatic glucagon, to which 8 additional residues are added at the C-terminal ends. Biological activities of pancreatic glucagon include glycogenolysis, lipolysis, gluconeogenesis, and ketogenesis, which have antagonistic effects of insulin action, resulting in an increase in blood glucose. Immunocytochemical studies have shown the presence of pancreatic glucagon within A or alpha cells, which account for 15 to 20% of the cell population of islets. These cells are preferentially located on the periphery of human pancreatic islets. Pathological manifestations of the glucagon-type peptide residue consist almost exclusively of tumours or glucagonomas, with no glucagon- or hyperplasia-deficiency status identified. The specific antibodies of glucagon would be useful as markers of cells and tumours using immunohistochemical techniques and as an analytical tool for the qualification of hormone.
Sensitivity
Sensitivity of the dosage: 2.5 pg/ml.
Measurement range
Dose range: 2.03 pg/ml to 130 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Specificity
This ELISA antibody detects human KLK. Other species not yet determined.